BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:15 AM | Browse: 375 | Download: 999
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 101325
Country Türkiye
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Assessment of new pathological markers in early stage colon cancer: Insights and limitations
Manuscript Source Unsolicited Manuscript
All Author List Bulent Erdogan, Fatma Elif Usturalı Keskin, Erkan Özcan, Ahmet Küçükarda, Ali Kaan Güren, Osman Köstek, Bekir Muhammet Hacioglu and Hilmi Kodaz
ORCID
Author(s) ORCID Number
Fatma Elif Usturalı Keskin http://orcid.org/0000-0003-0656-2576
Ahmet Küçükarda http://orcid.org/0000-0001-7399-2360
Ali Kaan Güren http://orcid.org/0000-0002-3562-5006
Hilmi Kodaz http://orcid.org/0000-0002-9366-816X
Funding Agency and Grant Number
Corresponding Author Hilmi Kodaz, Professor, Department of Medical Oncology, Acibadem Eskisehir Hospital, Hosnudiye District, Eskibaglar Street, No. 19 Tepebası, Eskisehir 26130, Türkiye. hilmikodaz@hotmail.com
Key Words Colon cancer; Early stage; Risk factors; New pathological markers; Tumor-stroma ratio; Tumor infiltrating lymphocytes; Crohn-like reaction; Desmoid reaction; Poorly differentiated clusters
Core Tip When their associations with the pathological marker in the risk group were evaluated, it was found that there was a significant correlation between the presence of poorly differentiated clusters (PDC) and the presence of PDC grade 3 and advanced T stage. This showed us that PDC is one of the markers to be used in cases where these risk factors are insufficient.
Publish Date 2025-02-14 10:33
Citation

Erdogan B, Usturalı Keskin FE, Özcan E, Küçükarda A, Güren AK, Köstek O, Hacioglu BM, Kodaz H. Assessment of new pathological markers in early stage colon cancer: Insights and limitations. World J Gastrointest Oncol 2025; 17(3): 101325

URL https://www.wjgnet.com/1948-5204/full/v17/i3/101325.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i3.101325
Full Article (PDF) WJGO-17-101325-with-cover.pdf